Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |